Correlation Between GlaxoSmithKline PLC and Morgan Stanley
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Morgan Stanley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Morgan Stanley into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Morgan Stanley, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Morgan Stanley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Morgan Stanley. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Morgan Stanley.
Diversification Opportunities for GlaxoSmithKline PLC and Morgan Stanley
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between GlaxoSmithKline and Morgan is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Morgan Stanley in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morgan Stanley and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Morgan Stanley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morgan Stanley has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Morgan Stanley go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Morgan Stanley
Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 26.07 times less return on investment than Morgan Stanley. In addition to that, GlaxoSmithKline PLC is 1.36 times more volatile than Morgan Stanley. It trades about 0.0 of its total potential returns per unit of risk. Morgan Stanley is currently generating about 0.04 per unit of volatility. If you would invest 1,921 in Morgan Stanley on August 27, 2024 and sell it today you would earn a total of 362.00 from holding Morgan Stanley or generate 18.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Morgan Stanley
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Morgan Stanley |
GlaxoSmithKline PLC and Morgan Stanley Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Morgan Stanley
The main advantage of trading using opposite GlaxoSmithKline PLC and Morgan Stanley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Morgan Stanley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morgan Stanley will offset losses from the drop in Morgan Stanley's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Morgan Stanley vs. Eastman Chemical | Morgan Stanley vs. NL Industries | Morgan Stanley vs. Codexis | Morgan Stanley vs. Axalta Coating Systems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |